Hetzer Medical Indonesia is trading at IDR 75.00, up +5.63%, with no credible August 31, 2026 company-specific announcement identified to explain the advance.
- Recent disclosures showed continued insider selling by commissioner and controlling shareholder Jemmy Kurniawan, including 3 million shares sold at IDR 70–71 on August 19.
- Broader markets were mixed, so the gain cannot be confidently attributed to global sentiment; the catalyst remains unclear and should be rechecked for delayed disclosures.